Latest Scripsamerica Inc (SCRC) Headlines Scrip
Post# of 7769
Posted On: 03/11/2014 7:12:38 AM
Latest Scripsamerica Inc (SCRC) Headlines
ScripsAmerica Secures $200,000 RapiMed Purchase Order for Hong Kong Market
GlobeNewswire - Mon Mar 10, 9:02AM CDT
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has secured a $200,000 purchase order for RapiMed(R) from Global Pharma Hub for the Hong Kong market.
ScripsAmerica Enters Licensing Agreement to Market and Distribute RapiMed in Canada
GlobeNewswire - Wed Mar 05, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has entered into a sublicensing agreement for the marketing and distribution of RapiMed(R) in Canada. ScripsAmerica will now have access to the growing Canadian OTC drug market, which was valued at over $3.1 Billion in 2012.
ScripsAmerica Signs Business Management Agreement With a New Jersey Compounding Pharmacy
GlobeNewswire - Thu Feb 20, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has entered into a business management agreement with a New Jersey compounding pharmacy.
ScripsAmerica Commences Prepayment of Convertible Notes
GlobeNewswire - Wed Feb 19, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company has commenced the prepayment of its outstanding convertible debt by issuing the first payment on its convertible note with the largest principal and closest conversion date.
ScripsAmerica's Pharmaceutical Equity Venture Generates Record Revenue for Second Consecutive Month
GlobeNewswire - Wed Feb 12, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC), today announced that during the month of January, the Company's equity venture, Wholesale Rx "WRx," received and processed $268,696 in orders, setting a second consecutive monthly revenue record.
ScripsAmerica's RapiMed Product Receives Registration Approval From the Hong Kong Government
GlobeNewswire - Mon Feb 10, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has received registration approval for its RapiMed(R) Children's Pain Reliever & Fever Reducer from the Government of Hong Kong.
ScripsAmerica Signs Joint Venture With Global Pharma Hub to License, Market and Distribute RapiMed in Hong Kong, China
GlobeNewswire - Mon Feb 03, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has entered into a joint venture with Global Pharma Hub, an international pharmaceutical marketing and distribution company, to license, market and distribute its RapiMed(R) Children's pain reliever and fever reducer.
ScripsAmerica's Pharmaceutical Joint Venture Generates Record Revenue in December
GlobeNewswire - Mon Jan 06, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC) today announced that the Company received and processed a record high $165,424 in orders from its pharmaceutical distribution joint venture (JV) during the month of December.
ScripsAmerica Enhances Website to Increase Shareholder Communication
GlobeNewswire - Mon Dec 30, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced the addition of a new section to the Company's website, www.scripsamerica.com, that will serve as a thorough source of shareholder information and be continuously updated by management.
Revenue from ScripsAmerica's Pharmaceutical Joint Venture on Record Pace for December
GlobeNewswire - Thu Dec 19, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company has received and processed a record high $51,920 in orders during the week ending December 13, 2013 and $84,821 in orders for the first two weeks of the month from its recent pharmaceutical distribution joint venture ("JV").
ScripsAmerica's Pharmaceutical Joint Venture Generates Over $116,000 in Revenue for November
GlobeNewswire - Wed Dec 18, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company has received and processed $116,987 in orders during November from its recent pharmaceutical distribution joint venture ("JV").
ScripsAmerica CEO Interview Featured on "The Stock Radio"
GlobeNewswire - Mon Dec 02, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company's CEO, Bob Schneiderman, has recently been interviewed by "The Stock Radio," a small cap research and investment commentary provider.
ScripsAmerica Moves to Finalize Negotiations With Major Chinese Distributors to Sell RapiMed(R) Throughout Asia
GlobeNewswire - Mon Nov 25, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company's recent business development trip to China has generated strong interest from multiple large entities for the distribution of its RapiMed(R) children's pain reliever throughout Asia.
ScripsAmerica Closes Equity Transaction With Institutional Investor Ironridge Consumer Co.
GlobeNewswire - Wed Nov 20, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company has satisfied $686,962 in trade payables and outstanding convertible notes in exchange for the issuance of shares of its common stock to Ironridge Consumer Co., a division of institutional investor Ironridge Global IV, Ltd. ("Ironridge") which specializes in direct equity investments in consumer product companies.
ScripsAmerica Comments on Revenue Recognition to Shareholders
GlobeNewswire - Tue Nov 19, 7:30AM CST
CEO of ScripsAmerica, Inc. (OTCBB:SCRC), Bob Schneiderman, today commented on revenue recognition regarding a Department of Defense (DoD) joint venture and Wholesale Rx in the Company's most recent 10Q filing.
News and Insights on SCRC, FARE and OCTX
ACCESSWIRE - Wed Nov 13, 1:02AM CST
News and Insights on ScripsAmerica Inc (OTC:SCRC), World Moto Inc (OTC:FARE) and Octagon 88 Resources Inc (OTC:OCTX).
ScripsAmerica Takes Equity Position in Tennessee Distributor Wholesale Rx
GlobeNewswire - Mon Nov 11, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC), today announced that it has agreed to invest in Wholesale Rx "WRx" in exchange for an equity position in the company.
In Depth Coverage on SCRC, TTNP, EWSI and SKTO
ACCESSWIRE - Wed Nov 06, 12:42AM CST
ScripsAmerica Inc (OTC:SCRC), Titan Pharmaceuticals Inc (OTC:TTNP), E-Waste Systems Inc (OTC:EWSI) and SK3 Group Inc. (OTC:SKTO) have been added to our watch list.
Revenue from ScripsAmerica's Pharmaceutical Joint Venture Tops $129,000 for October
GlobeNewswire - Mon Nov 04, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company has received and processed $129,794 in orders during October from its recent pharmaceutical distribution joint venture
Stocks In Focus: XUII, NHYT, SCRC and TALK
ACCESSWIRE - Thu Oct 31, 12:47AM CDT
Medora Corp (OTC:XUII), Neohydro Technologies Corp (OTC:NHYT), ScripsAmerica Inc (OTC:SCRC) and iTalk Inc (OTC:TALK) are stocks in focus for today.
ScripsAmerica Secures $200,000 RapiMed Purchase Order for Hong Kong Market
GlobeNewswire - Mon Mar 10, 9:02AM CDT
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has secured a $200,000 purchase order for RapiMed(R) from Global Pharma Hub for the Hong Kong market.
ScripsAmerica Enters Licensing Agreement to Market and Distribute RapiMed in Canada
GlobeNewswire - Wed Mar 05, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has entered into a sublicensing agreement for the marketing and distribution of RapiMed(R) in Canada. ScripsAmerica will now have access to the growing Canadian OTC drug market, which was valued at over $3.1 Billion in 2012.
ScripsAmerica Signs Business Management Agreement With a New Jersey Compounding Pharmacy
GlobeNewswire - Thu Feb 20, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has entered into a business management agreement with a New Jersey compounding pharmacy.
ScripsAmerica Commences Prepayment of Convertible Notes
GlobeNewswire - Wed Feb 19, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company has commenced the prepayment of its outstanding convertible debt by issuing the first payment on its convertible note with the largest principal and closest conversion date.
ScripsAmerica's Pharmaceutical Equity Venture Generates Record Revenue for Second Consecutive Month
GlobeNewswire - Wed Feb 12, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC), today announced that during the month of January, the Company's equity venture, Wholesale Rx "WRx," received and processed $268,696 in orders, setting a second consecutive monthly revenue record.
ScripsAmerica's RapiMed Product Receives Registration Approval From the Hong Kong Government
GlobeNewswire - Mon Feb 10, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has received registration approval for its RapiMed(R) Children's Pain Reliever & Fever Reducer from the Government of Hong Kong.
ScripsAmerica Signs Joint Venture With Global Pharma Hub to License, Market and Distribute RapiMed in Hong Kong, China
GlobeNewswire - Mon Feb 03, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company has entered into a joint venture with Global Pharma Hub, an international pharmaceutical marketing and distribution company, to license, market and distribute its RapiMed(R) Children's pain reliever and fever reducer.
ScripsAmerica's Pharmaceutical Joint Venture Generates Record Revenue in December
GlobeNewswire - Mon Jan 06, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC) today announced that the Company received and processed a record high $165,424 in orders from its pharmaceutical distribution joint venture (JV) during the month of December.
ScripsAmerica Enhances Website to Increase Shareholder Communication
GlobeNewswire - Mon Dec 30, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced the addition of a new section to the Company's website, www.scripsamerica.com, that will serve as a thorough source of shareholder information and be continuously updated by management.
Revenue from ScripsAmerica's Pharmaceutical Joint Venture on Record Pace for December
GlobeNewswire - Thu Dec 19, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company has received and processed a record high $51,920 in orders during the week ending December 13, 2013 and $84,821 in orders for the first two weeks of the month from its recent pharmaceutical distribution joint venture ("JV").
ScripsAmerica's Pharmaceutical Joint Venture Generates Over $116,000 in Revenue for November
GlobeNewswire - Wed Dec 18, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company has received and processed $116,987 in orders during November from its recent pharmaceutical distribution joint venture ("JV").
ScripsAmerica CEO Interview Featured on "The Stock Radio"
GlobeNewswire - Mon Dec 02, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company's CEO, Bob Schneiderman, has recently been interviewed by "The Stock Radio," a small cap research and investment commentary provider.
ScripsAmerica Moves to Finalize Negotiations With Major Chinese Distributors to Sell RapiMed(R) Throughout Asia
GlobeNewswire - Mon Nov 25, 7:30AM CST
ScripsAmerica, Inc. (OTCBB:SCRC) today announced that the Company's recent business development trip to China has generated strong interest from multiple large entities for the distribution of its RapiMed(R) children's pain reliever throughout Asia.
ScripsAmerica Closes Equity Transaction With Institutional Investor Ironridge Consumer Co.
GlobeNewswire - Wed Nov 20, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company has satisfied $686,962 in trade payables and outstanding convertible notes in exchange for the issuance of shares of its common stock to Ironridge Consumer Co., a division of institutional investor Ironridge Global IV, Ltd. ("Ironridge") which specializes in direct equity investments in consumer product companies.
ScripsAmerica Comments on Revenue Recognition to Shareholders
GlobeNewswire - Tue Nov 19, 7:30AM CST
CEO of ScripsAmerica, Inc. (OTCBB:SCRC), Bob Schneiderman, today commented on revenue recognition regarding a Department of Defense (DoD) joint venture and Wholesale Rx in the Company's most recent 10Q filing.
News and Insights on SCRC, FARE and OCTX
ACCESSWIRE - Wed Nov 13, 1:02AM CST
News and Insights on ScripsAmerica Inc (OTC:SCRC), World Moto Inc (OTC:FARE) and Octagon 88 Resources Inc (OTC:OCTX).
ScripsAmerica Takes Equity Position in Tennessee Distributor Wholesale Rx
GlobeNewswire - Mon Nov 11, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC), today announced that it has agreed to invest in Wholesale Rx "WRx" in exchange for an equity position in the company.
In Depth Coverage on SCRC, TTNP, EWSI and SKTO
ACCESSWIRE - Wed Nov 06, 12:42AM CST
ScripsAmerica Inc (OTC:SCRC), Titan Pharmaceuticals Inc (OTC:TTNP), E-Waste Systems Inc (OTC:EWSI) and SK3 Group Inc. (OTC:SKTO) have been added to our watch list.
Revenue from ScripsAmerica's Pharmaceutical Joint Venture Tops $129,000 for October
GlobeNewswire - Mon Nov 04, 7:30AM CST
ScripsAmerica Inc. (OTCBB:SCRC), today announced that the Company has received and processed $129,794 in orders during October from its recent pharmaceutical distribution joint venture
Stocks In Focus: XUII, NHYT, SCRC and TALK
ACCESSWIRE - Thu Oct 31, 12:47AM CDT
Medora Corp (OTC:XUII), Neohydro Technologies Corp (OTC:NHYT), ScripsAmerica Inc (OTC:SCRC) and iTalk Inc (OTC:TALK) are stocks in focus for today.
(0)
(0)ScripsAmerica Inc (SCRC) Stock Research Links
Scroll down for more posts ▼